South Korea PEG-modified Drugs Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 1.0 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
The South Korea PEG-modified Drugs Market is experiencing significant growth due to increasing applications in the pharmaceutical and biotechnology industries. PEG-modified drugs, which are typically designed by attaching polyethylene glycol (PEG) to therapeutic molecules, enhance their pharmacokinetics, stability, and solubility. These advantages have made PEG-modified drugs a sought-after option for treatments in oncology, autoimmune diseases, and chronic conditions. As industries continue to prioritize innovation in drug delivery systems, the demand for PEG-modified drugs is expected to surge, driving the market's expansion in South Korea.
One of the key drivers of this market is the increasing focus on biopharmaceuticals, particularly in cancer treatment. PEGylation, or the process of attaching PEG molecules to therapeutic proteins or peptides, has been shown to improve the half-life of these drugs, which is essential in providing prolonged efficacy for patients. For instance, PEGylated interferon-alpha has become a critical treatment for hepatitis C and certain cancers. South Korea, known for its advanced healthcare system and growing biotech industry, is positioning itself as a hub for the development and production of these drugs.
Pharmaceutical companies and researchers in South Korea are placing heavy emphasis on meeting the rising requirements for PEG-modified drugs. The need for more stable and effective drug formulations has driven the demand for PEGylation techniques. South Korea's regulatory framework for biotechnology is another contributing factor. With clear guidelines and government support, the environment is ripe for the development of innovative PEG-modified drugs.
Furthermore, the demand for PEG-modified drugs is also influenced by the need for personalized medicine. As more treatments are tailored to the genetic makeup of patients, PEGylation has proven to be a valuable tool in optimizing drug delivery and minimizing side effects. This has paved the way for personalized PEG-modified therapies, especially in areas like cancer immunotherapy.
The pharmaceutical and biotechnology industries in South Korea require not only advanced research and development but also cutting-edge manufacturing technologies. Companies involved in PEG-modified drug production need state-of-the-art facilities, efficient processes, and adherence to global standards to stay competitive. With growing collaborations between local companies and international stakeholders, the PEG-modified drugs market in South Korea is set for sustained growth in the coming years.
Get an In-Depth Research Analysis of the South Korea PEG-modified Drugs Market Size And Forecast [2025-2032]
Â
Merck Sharp & Dohme
Baxalta Inc.
Amgen Inc.
Roche
UCB S.A.
Enzon
Horizon Pharma Plc
Biogen Inc.
Qilu Pharmaceutical Co.
Ltd.
CSPC Baike (Shandong) Biopharmaceutical Co.
Ltd.
Changchun Genescience Pharmaceutical Co.
Ltd.
Xiamen Amoytop Biotech Co.
Ltd.
Jiangsu Hengrui Pharmaceuticals Co.
Ltd.
Hansoh Pharmaceuticak Group Co.
Ltd.
SunBio
Xiamen Sano banger Biotechnology Co.
Ltd
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea PEG-modified Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea PEG-modified Drugs Market
Monomethoxy Poly(ethylene glycol) (MPEG)
Polyethylene glycol (PEG) Derivatives
PEGylated Proteins
PEGylated Nanoparticles
PEG-Modified Antibodies
Oncology
Autoimmune Diseases
Genetic Disorders
Infectious Diseases
Andrology and Gynecology
Intravenous (IV)
Subcutaneous (SC)
Intramuscular (IM)
Oral
Topical
Preclinical Stage
Phase I Clinical Trials
Phase II Clinical Trials
Phase III Clinical Trials
Marketed Products
Pharmaceutical Companies
Biotechnology Firms
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospitals and Clinics
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea PEG-modified Drugs Market Research Analysis
1. Introduction of the South Korea PEG-modified Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea PEG-modified Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea PEG-modified Drugs Market, By Type
6. South Korea PEG-modified Drugs Market, By Application
7. South Korea PEG-modified Drugs Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea PEG-modified Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/